Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) Non Operating Income (2016 - 2025)

Mimedx's Non Operating Income history spans 11 years, with the latest figure at -$185000.0 for Q4 2025.

  • For Q4 2025, Non Operating Income rose 11.06% year-over-year to -$185000.0; the TTM value through Dec 2025 reached -$558000.0, up 1.24%, while the annual FY2025 figure was -$558000.0, 1.24% up from the prior year.
  • Non Operating Income for Q4 2025 was -$185000.0 at Mimedx, down from -$126000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $16000.0 in Q4 2023 and bottomed at -$237000.0 in Q2 2024.
  • The 5-year median for Non Operating Income is -$32000.0 (2023), against an average of -$78266.7.
  • The largest annual shift saw Non Operating Income soared 633.33% in 2023 before it tumbled 5050.0% in 2024.
  • A 5-year view of Non Operating Income shows it stood at -$20000.0 in 2021, then surged by 85.0% to -$3000.0 in 2022, then skyrocketed by 633.33% to $16000.0 in 2023, then plummeted by 1400.0% to -$208000.0 in 2024, then rose by 11.06% to -$185000.0 in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Non Operating Income are -$185000.0 (Q4 2025), -$126000.0 (Q3 2025), and -$102000.0 (Q2 2025).